Thus far in 2017, the University of California Los Angeles has received over $6.8 million in funding from the National Heart Lung and Blood Institute (NHLBI). This funding has been awarded through multiple grants intended to support cardiovascular research.Read More
Science Market Update
Tags: University of California Los Angeles, cardiovascular research, increase laboratory product sales, UCLA, NIH funding, life science research at UCLA, life science solutions, science solutions, NIH awards 2017
If you're a researcher in Atlanta, you have the opportunity to meet other researchers and learn about the latest life science solutions on the market by attending Biotechnology Calendar, Inc.’s Emory University life science marketing event. Our Atlanta BioResearch Product Faire™ Event will be held on February 27th, 2014. Last year, our Atlanta BioResearch Product Faire™ Event attracted 213 attendees. This year, make sure you don't miss out on our popular Emory event where hundreds of your colleagues will enjoy one another's company, a free catered lunch and door prizes.
A new study by researchers at the University of Pennsylvania has findings that suggest a new way ECMO, or extracorporeal membrane oxygenation, can help treat patients with shock and cardiac arrest. ECMO has been used in the past during cardiac surgeries as a way to replace patients’ heart and lung function. According to Health Canal, researchers at the University of Pennsylvania have made a breakthrough in using this intervention to save the lives of patients who are unable to be resuscitated.
Tags: 2014, 2013, Pennsylvania, Northeast, University of Pennsylvania, UPenn, Philadelphia, BioResearch Product Faire Event, PA, university lab equipment, life science solutions, life science marketing event
It is implicit that marketing life science solutions at a high quality life science marketing vendor show in Boston will result in excellent biotech sales leads, especially when one takes into account The Boston Globe’s recent report on the biotech industry boom in Boston. At least nine life science companies in Massachusetts could go public this year, making the boom one of the biggest since 2007.